Napro Biotherap(npro) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Napro Biotherap(npro)

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: trevor john wilkinson who started this subject	9/7/2002 12:45:41 AM
From: John McCarthy	of 478

NAPRO - EUROPEAN PATENT - DELIVERY OF TAXANES Part 3 of 3 posts Part 3:BIBLIO Patent Number: WO9945918 Publication date: 1999-09-16 Inventor(s): MCCHESNEY-HARRIS LISA L Applicant(s): NAPRO BIOTHERAPEUTICS INC (US) Requested Patent: ZA9901885 Application Number: WO1999US05151 19990310 Priority Number(s): US19980077459P 19980310 IPC Classification: A61K31/335; A61K47/22 EC Classification: A61K47/00R, A61K9/107D, A61K9/48H4, A61K31/335L Equivalents: AU2902299, BR9904856, EP0977562 (WO9945918), JP2001524988T Cited Documents: WO9511039; WO9830205 Abstract Methods and compositions for delivery of taxanes are disclosed. Particularly disclosed are compositions of taxol solubilized in Vitamin E TPGS whereby the delivery of taxol is improved. l2.espacenet.com John McCarthy

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next